Mahdi Behdani

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 9

Top Topics

Escherichia Coli

Vascular Endothelial Growth Factor

Tandem Mass Spectrometry

Heat Shock Protein

Top Venues

Current protein & peptide science

Molecular biotechnology

This page only lists publications with an associated author ORCID identifier.

Publications

Mohammad Hosseininejad Chafi, Mohsen Eslamnezhad-Namin, Mansoureh Shahbazi Dastjerdeh, Mohammad Reza Zareinejad, Akbar Oghalaie, Kamran Pooshang Bagheri, Fatemeh Kazemi-Lomedasht, Gholamreza Karimi, Mehdi Razzaghi-Abyaneh, Sima Sadat Seyedjavadi, Mahdi Behdani
CTXP, The Major Cobra Toxin Peptide from Naja Naja Oxiana Venom; A Promising Target for Antivenom Agent Development. Current protein & peptide science 25 (6) (2024)
Mohammad Hosseininejad Chafi, Mohsen Eslamnezhad-Namin, Mansoureh Shahbazi Dastjerdeh, Mohammad Reza Zareinejad, Akbar Oghalaie, Kamran Pooshang Bagheri, Fatemeh Kazemi-Lomedasht, Gholamreza Karimi, Mehdi Razzaghi-Abyaneh, Sima Sadat Seyedjavadi, Mahdi Behdani
CTXP, The Major Cobra Toxin Peptide From Naja Naja Oxiana Venom; A Promising Target for Antivenom Agent Development. Current protein & peptide science (2024)
Arezoo Beig Parikhani, Rada Dehghan, Yeganeh Talebkhan Garoosi, Elham Bayat, Ali Reza Biglari, Mohammad Ali Shokrgozar, Reza Ahangari Cohan, Esmat Mirabzadeh, Soheila Ajdary, Mahdi Behdani
A novel nanobody-based immunocytokine of a mutant interleukin-2 as a potential cancer therapeutic. AMB Express 14 (1) (2024)
Mohammad Hosseininejad Chafi, Mohsen Eslamnezhad-Namin, Mansoureh Shahbazi Dastjerdeh, Mohammad Reza Zareinejad, Akbar Oghalaie, Kamran Pooshang Bagheri, Fatemeh Kazemi-Lomedasht, Gholamreza Karimi, Mehdi Razzaghi-Abyaneh, Sima Sadat Seyedjavadi, Mahdi Behdani
CTXP, The Major Cobra Toxin Peptide from Naja Naja Oxiana Venom; A Promising Target for Antivenom Agent Development. Current protein & peptide science 25 (6) (2024)
Arezoo Beig Parikhani, Rada Dehghan, Yeganeh Talebkhan Garoosi, Elham Bayat, Ali Reza Biglari, Mohammad Ali Shokrgozar, Reza Ahangari Cohan, Esmat Mirabzadeh, Soheila Ajdary, Mahdi Behdani
A novel nanobody-based immunocytokine of a mutant interleukin-2 as a potential cancer therapeutic. AMB Express 14 (1) (2024)
Rasoul Mardani-Jouneghani, Shiva Irani, Mahdi Habibi-Anbouhi, Mahdi Behdani
Development and Characterization of a Novel Single-Chain Antibody Against B-Cell Activating Factor. Molecular biotechnology (2023)
Vahab Ziaei, Ali Reza Ghassempour, Fatemeh Davami, Bahareh Azarian, Mahdi Behdani, Hamed Dabiri, Mahdi Habibi-Anbouhi
Production and characterization of a camelid single domain anti-CD22 antibody conjugated to DM1. Molecular and cellular biochemistry (2023)
Arezoo Beig Parikhani, Kowsar Bagherzadeh, Rada Dehghan, Alireza Biglari, Mohammad Ali Shokrgozar, Farhad Riazi Rad, Sirous Zeinali, Yeganeh Talebkhan, Soheila Ajdary, Reza Ahangari Cohan, Mahdi Behdani
Human IL-2Rɑ subunit binding modulation of IL-2 through a decline in electrostatic interactions: A computational and experimental approach. PloS one 17 (2) (2022)
Zahra Naderiyan, Nazli Sotoudeh, Alireza Shoari, Hajarossadat Ghaderi, Mahdi Habibi-Anbouhi, Reza Moazzami, Reza Ahangari Cohan, Mahdi Behdani
In Vitro and In Vivo Studies of a Heminecrolysin Toxin-VEGF Fusion Protein as a Novel Therapeutic for Solid Tumor Targeting. Molecular biotechnology (2022)